Danahy Kevin Patrick
CIK 0001913245
Chief Executive Officer
Filings
12
Latest Feb 23, 2026
Issuers covered
1
Showing
12 of 12
Page 1
Track record
13 of 13 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 13 | 92% | +19.4% | +11.6% | +56.3% | -3.4% |
| 90 days | 13 | 77% | +16.5% | +20.2% | +40.7% | -17.8% |
| 180 days | 6 | 50% | +1.3% | +4.8% | +23.2% | -27.8% |
| 365 days | 3 | 100% | +166.7% | +166.7% | +166.7% | +166.7% |
Issuers
Companies where Danahy Kevin Patrick has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PLSE | Pulse Biosciences, Inc. | 12 | Feb 23, 2026 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|